Merit Medical Systems IncMMSI
Price$86.15Intrinsic value$98.9415% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $98.94median of 6 methods · middle span $75-$134based on filings through 30 Jun 2026
Market Price $86.15Price as of 1 Oct 2026
Margin of Safety +14.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 9.3% (near-term consensus, capped) · years 2–5: 9.0%/yr (balance of the path).9.0% per year
Years 6–10: glide to demonstrated growth own history 41.4%, capped at 20%
Per-year rates
Yr 69.0%Yr 79.0%Yr 89.0%Yr 99.0%Yr 109.0%
9.0% → 9.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.4%Yr 127.8%Yr 137.2%Yr 146.6%Yr 156.0%Yr 165.4%Yr 174.8%Yr 184.2%Yr 193.6%Yr 203.0%
9.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)41.4%
Discount rate (cost of equity) 8.0%
Volatility vs market (adjusted beta)0.67

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetMerit Medical Systems IncMMSIHealth Care
Valuation
P/E35.5×
P/S3.2×
P/B3.0×
EV / Revenue3.4×
EV / EBITDA—
Profitability
Gross margin48.4%
Operating margin11.6%
Net margin9.2%
FCF margin12.9%
Returns
ROE8.7%
ROA5.1%
ROIC7.4%
Growth
Revenue growth (YoY)16.4%
5-yr fwd EPS growth9.0%
Financial strength
Debt / Equity0.44×
Current ratio4.20×
Altman Z-Score4.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.